AboGen
2011
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Angel
LATEST DEAL TYPE
$25K
LATEST DEAL AMOUNT
2
INVESTORS
Description
Developer of a medical device designed to preserve components of saliva for medical tests. The company's medical device uses a saliva collection and preservation technology to preserve all the components in saliva and replace blood tests performed annually, enabling physicians to reduce blood tests and increase diagnosis accuracy.
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Other Devices and Supplies
Primary Office
- 477 Congress Street
- Suite 1010
- Portland, ME 04101
- United States
+1 (207) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore AboGen’s full profile, request a free trial.
AboGen Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Angel (individual) | 28-Jul-2017 | $25K | 00000 | Completed | Startup | |
| 2. Convertible Debt | 01-Mar-2015 | 00000 | 00000 | Completed | Startup | |
| 1. Debt - General | 16-Dec-2013 | $430K | $430K | Completed | Startup |
AboGen Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Boynton Angels | Angel Group | 000 0000 | 000000 0 | |||
| Maine Angels | Angel Group | 000 0000 | 000000 0 |
AboGen Executive Team (3)
AboGen Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Fred Heimann | AboGen | Board Member | 000 0000 | |
| Jacques Essinger | AboGen | Board Member | 000 0000 | |
| Ken Martin | AboGen | Board Member | 000 0000 | |
| Stephen Andrews Ph.D | AboGen | Co-Founder, Chief Executive Officer & Board Member | 000 0000 | |
| Youssef Biadillah | Self | Co-Founder, President, Chief Operating Officer & Board Member | 000 0000 |